Close Menu

This article has been updated with details from Invitae's Q3 earnings call.

NEW YORK (GenomeWeb) – Invitae reported after the close of the market Monday a nearly threefold year-over-year increase in third quarter revenues.

For the three months ended Sept. 30, Invitae reported $6.3 million in third quarter revenues compared to $2.2 million in the year ago period, but falling short of the consensus Wall Street estimate of $7.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.